E2F1 down-regulation promotes lipid droplet accumulation and endometriosis development through impaired MGLL-mediated lipid mobilization
E2F1 downregulation impairs MGLL-mediated lipid mobilization, promoting lipid droplet accumulation and endometriosis development through altered phospholipid and cholesterol levels in ectopic stromal cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (72)
- Body mass index in endometriosis via openalex
- C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis via openalex
- Clinical practice. Endometriosis via openalex
- Correlation between lipid metabolism and endometriosis: a meta-analysis via openalex
- Diagnostic Value of Menstrual Blood Lipidomics in Endometriosis: A Pilot Study via openalex
- Discovery of Phosphatidic Acid, Phosphatidylcholine, and Phosphatidylserine as Biomarkers for Early Diagnosis of Endometriosis via openalex
- Elevated serum lipoprotein(a) levels in young women with endometriosis via openalex
- Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of endometriosis via openalex
- Endometrial-peritoneal interactions during endometriotic lesion establishment via openalex
- Endometriosis is not the endometrium: Reviewing the over-representation of eutopic endometrium in endometriosis research via openalex
- Endometriosis: recent advances that could accelerate diagnosis and improve care via openalex
- Endometrium and endometriosis tissue mitochondrial energy metabolism in a nonhuman primate model via openalex
- ERβ-activated LINC01018 promotes endometriosis development by regulating the CDC25C/CDK1/CyclinB1 pathway via openalex
- Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator via openalex
- Integration analysis of microRNA and mRNA paired expression profiling identifies deregulated microRNA-transcription factor-gene regulatory networks in ovarian endometriosis via openalex
- Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro via openalex
- Knockdown of long noncoding RNA CCDC144NL-AS1 attenuates migration and invasion phenotypes in endometrial stromal cells from endometriosis† via openalex
- Metabolic reprogramming in endometriosis: mechanisms and therapeutic prospects via openalex
- Metabolomics in endometriosis: challenges and perspectives for future studies via openalex
- Nonhormonal therapy for endometriosis based on energy metabolism regulation via openalex
- Pathophysiology, diagnosis, and management of endometriosis via openalex
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review via openalex
- PrPC Promotes Endometriosis Progression by Reprogramming Cholesterol Metabolism and Estrogen Biosynthesis of Endometrial Stromal Cells through PPARα Pathway via openalex
- Relationship between triglyceride-glucose index and endometriosis: a cross-sectional analysis via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis via openalex
- Understanding the molecular mechanisms of macrophage polarization and metabolic reprogramming in endometriosis: A narrative review via openalex
- Warburg-like Metabolic Reprogramming in Endometriosis: From Molecular Mechanisms to Therapeutic Approaches via openalex
- W4380319688 via openalex
- W4386471647 via openalex
- W4388416895 via openalex
- W4391537439 via openalex
- W4394620630 via openalex
- W4394726364 via openalex
- W4399202410 via openalex
- W4400240889 via openalex
- W4406360596 via openalex
- W4412635745 via openalex
- W4412724882 via openalex
- W4415381438 via openalex
- W4416531306 via openalex
- W4417068348 via openalex
- W7124251422 via openalex
- W7133887257 via openalex
- W7168852211 via openalex
- W1706150252 via openalex
- W1975229775 via openalex
- W1980759602 via openalex
- W1984252723 via openalex
- W2063297728 via openalex
- W2065343028 via openalex
- W2121233961 via openalex
- W2127624416 via openalex
- W2163953252 via openalex
- W2178023527 via openalex
- W2185464160 via openalex
- W2280082157 via openalex
- W2609484747 via openalex
- W2740141750 via openalex
- W2768073235 via openalex
- W2809921982 via openalex
- W2903107073 via openalex
- W2980866465 via openalex
- W2988365714 via openalex
- W3134885188 via openalex
- W3137440484 via openalex
- W3161968936 via openalex
- W3165294846 via openalex
- W3203453680 via openalex
- W4376875205 via openalex
- W4379052379 via openalex
- W4379618280 via openalex
Source provenance
- europepmc
- last seen: 2026-10-17T06:09:56.316927+00:00
- openalex
- last seen: 2026-10-17T06:00:36.336285+00:00
- pubmed
- last seen: 2026-10-17T06:02:14.733988+00:00
Courtesy of the U.S. National Library of Medicine